Back to Agenda
IMEDS: A Public-Private Partnership to Facilitate Real World Evidence Generation Based on the FDA's Sentinel System
Session Chair(s)
June Wasser, MA
Executive Director, Reagan-Udall Foundation For the FDA, United States
The Reagan-Udall Foundation for the FDA will introduce the IMEDS program to facilitate engagement with industry and other researchers to utilize the same tools and methods developed for the FDA's Sentinel System. IMEDS provides the opportunity to leverage expertise and standardized processes for the rapid and robust analysis of regulated products in a post-market setting. The panel will discuss the IMEDS process, characteristics of the IMEDS system as well as an overview of the IMEDS experience.
Learning Objective : Demonstrate a robust understanding of IMEDS, its capabilities, and characteristics; Discuss broad-use cases as well as potential enhancements to IMEDS
Speaker(s)
Overview of the IMEDS Program
Vice President, Head, PCO Center of Excellence, Novartis, United States
Panelist
Vice President, Epidemiology, Worldwide Regulatory and Safety, Pfizer Inc, United States
Panelist
Director of Clinical Epidemiology, HealthCore Inc., United States
Panelist
Associate Professor, Department of Population Medicine, Harvard Pilgrim Health Care Institute/Harvard Medical School, United States
Have an account?